Verano HoldingsVRNOD +0.19%65 Days Payable is 28.28 as of Mar. 2026, which is 2% below its 10-year median of 28.81. GuruFocus rates VRNOD with a GF Score™ of 65/100 and a GF Value™ of $7.76 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 923 Drug Manufacturers companies, Verano Holdings ranks worse than 86.13% on this metric.
The historical rank and industry rank for Verano Holdings's Days Payable or its related term are showing as below:
VRNOD'
s Days Payable Range Over the Past 10 Years
Min: 0.24 Med: 28.81 Max: 35.77
Current: 35.35
During the past 7 years, Verano Holdings's highest Days Payable was 35.77. The lowest was 0.24. And the median was 28.81.
VRNOD's Days Payable is ranked worse than 86.13% of 923
companies
in the Drug Manufacturers industry
Industry Median: 90.98
vs VRNOD: 35.35
Verano Holdings's Days Payable
declined
from Mar. 2025 (35.32) to Mar. 2026 (28.28).
It may suggest that Verano Holdingsaccelerated paying its suppliers.
Verano Holdings Days Payable Related Terms
Verano Holdings Days Payable Historical Data
* Premium members only.
The historical data trend for Verano Holdings's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Verano Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Verano Holdings Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Verano Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where Verano Holdings's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Verano Holdings's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Verano Holdings (VRNOD) has a Days Payable of 28.28 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Verano Holdings and its competitors. This is near median its historical median of 28.81. Over the past decade, Verano Holdings' Days Payable has ranged from 0.24 to 35.77. According to the industry distribution chart, Verano Holdings ranks #795 out of 923 companies in the Drug Manufacturers industry, placing it in the top 86.1%.
Is Verano Holdings' Days Payable too high?
Verano Holdings' current Days Payable of 28.28 is near median its 10-year median of 28.81. Over the past 10 years, this metric has ranged from a low of 0.24 to a high of 35.77. The Drug Manufacturers industry median Days Payable is 90.98. Verano Holdings' value of 28.28 is 68.9% below this industry median. Based on the distribution chart, Verano Holdings ranks #795 out of 923 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Verano Holdings has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Verano Holdings' Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Verano Holdings ranks #795 out of 923 companies for Days Payable. This places Verano Holdings in the lower half of its industry. The industry median Days Payable is 90.98. Verano Holdings' value of 28.28 is 68.9% below this benchmark. Historically, Verano Holdings' own Days Payable has ranged from 0.24 to 35.77 over the past decade. While the company's 10-year median is 28.81 vs. the industry median of 90.98, Verano Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.98, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Verano Holdings's current Days Payable of 28.28 is 68.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Verano Holdings and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Verano Holdings's current Days Payable is 28.28, which is near median its own 10-year median of 28.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Verano Holdings stock overvalued right now?
Based on GuruFocus' analysis, Verano Holdings (VRNOD) is currently considered Possible Value Trap. The stock's GF Value™ is $7.76, compared to a current price of $5.31 — trading 31.6% below its estimated fair value. The current Days Payable is 28.28, which is near median its 10-year median of 28.81 and 68.9% below the Drug Manufacturers industry median of 90.98. Verano Holdings' overall GF Score™ is 65/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Verano Holdings (VRNOD), the current Days Payable is 28.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Verano Holdings (VRNOD) Overvalued in 2026?
Based on GuruFocus' analysis, Verano Holdings stock appears to be undervalued.
The current stock price of $5.31 is trading 31.6% below its estimated GF Value™ of $7.76.
GuruFocus considers Verano Holdings to be Possible Value Trap.
Key valuation signals for VRNOD:
Days Payable: 28.28 (near median its 10-year median of 28.81)
GF Value™: $7.76 vs. price of $5.31 (31.6% below fair value)
Industry Position: 68.9% below the Drug Manufacturers median (#795 of 923)
No single metric tells the full story. See the VRNOD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Verano Holdings Corp is a vertically integrated, multi-state cannabis operator in the United States. The company operates through cultivation (wholesale) and retail segments. Its consumer brands include Encore, Avexia, MUV, Savvy, BITS, and Verano, while its retail dispensaries operate under brands such as Zen Leaf and MUV. The company derives the majority of its revenue from the retail segment.
65GF Score
Get the complete analysis for VRNOD
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VRNOD has been successfully added to your 
